Dr Gabriel Markson, PhD

Co-founder & Managing Partner

Instrumental in EUR >15 Billion of realized Private Equity transaction value over the course of his career.

Expert in identifying, acquiring, and exiting Life Sciences companies, assets, and technologies set for greatness.

Life Sciences entrepreneur and M&A practitioner focused on buying and improving European Life Sciences investments, including those backed by one of the world’s largest financial investors. Operational Management of portfolio companies of Nordic Capital, EQT, and Investor, focused on driving strategy, corporate development, operational transformations, and exits.

Molecular Biologist at the Cambridge Institute for Medical Research (CIMR), PhD in Molecular and Cell Biology from University of Cambridge; BSc Hons in Biological Sciences with Honours in Genetics from The University of Edinburgh.